Fukuda, Sanae, Nojima, Junzo, Kajimoto, Osami et al. · BioFactors (Oxford, England) · 2016 · DOI
This study tested whether taking a supplement called ubiquinol-10 (a form of coenzyme Q10) could help people with ME/CFS feel better. Researchers first gave 20 patients ubiquinol-10 for 8 weeks and saw improvements, then tested it more rigorously in 43 patients who either received ubiquinol-10 or a placebo for 12 weeks. The results suggested that ubiquinol-10 may help improve some CFS symptoms, particularly problems with nerve function and thinking ability.
ME/CFS patients frequently report cognitive dysfunction and autonomic symptoms such as orthostatic intolerance and dysautonomia, which significantly impair quality of life. If ubiquinol-10 supplementation can improve these core symptoms, it offers a potentially safe, non-pharmacological intervention that patients could access relatively easily, addressing mechanisms of cellular energy production that may be impaired in ME/CFS.
This study does not prove ubiquinol-10 is a cure for ME/CFS or that it works for all patients or all ME/CFS symptoms. The small sample size and incomplete RCT data (only 72% completion rate) mean results may not generalize broadly, and the mechanism by which ubiquinol-10 improves symptoms remains unclear. Additionally, the open-label phase was subject to placebo effect and observer bias, which may have inflated initial benefit estimates.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →